Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 23 April 1982:
Vol. 216. no. 4544, pp. 429 - 431
DOI: 10.1126/science.6176024
Prev | Table of Contents | Next

Articles

Science, Vol 216, Issue 4544, 429-431
Copyright © 1982 by American Association for the Advancement of Science

articles

Systemic lupus erythematosus: presence in human serum of an unusual acid-labile leukocyte interferon

OT Preble, RJ Black, RM Friedman, JH Klippel, and J Vilcek

A previously undescribed species of human leukocyte, or alpha, interferon is present in the serum of many patients with systemic lupus erythematosus. It was shown to be alpha-interferon by neutralization with specific antiserums, affinity column chromatography, and antiviral activity on bovine cells. However, 23 of 30 interferon samples tested were inactivated by incubation at pH 2, a characteristic of human "immune," or gamma, interferon. Multiple samples of interferon from the same patient had similar biological properties, but samples from different patients were not all identical, suggesting that several variants of this species of human alpha-interferon may exist.


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Early onset of autoimmune disease by the retroviral integrase inhibitor raltegravir.
G. B. Beck-Engeser, D. Eilat, T. Harrer, H.-M. Jack, and M. Wabl (2009)
PNAS 106, 20865-20870
   Abstract »    Full Text »    PDF »
Plasmacytoid Dendritic Cells Regulate Autoreactive B Cell Activation via Soluble Factors and in a Cell-to-Cell Contact Manner.
C. Ding, Y. Cai, J. Marroquin, S. T. Ildstad, and J. Yan (2009)
J. Immunol. 183, 7140-7149
   Abstract »    Full Text »    PDF »
Type I Interferons Produced by Resident Renal Cells May Promote End-Organ Disease in Autoantibody-Mediated Glomerulonephritis.
A.-M. Fairhurst, C. Xie, Y. Fu, A. Wang, C. Boudreaux, X. J. Zhou, R. Cibotti, A. Coyle, J. E. Connolly, E. K. Wakeland, et al. (2009)
J. Immunol. 183, 6831-6838
   Abstract »    Full Text »    PDF »
IFN{alpha} kinoid vaccine-induced neutralizing antibodies prevent clinical manifestations in a lupus flare murine model.
D. Zagury, H. Le Buanec, A. Mathian, P. Larcier, R. Burnett, Z. Amoura, D. Emilie, G. Peltre, A. Bensussan, B. Bizzini, et al. (2009)
PNAS 106, 5294-5299
   Abstract »    Full Text »    PDF »
Hematopoietic cell-derived interferon controls viral replication and virus-induced disease.
P. A. Lang, L. Cervantes-Barragan, A. Verschoor, A. A. Navarini, M. Recher, M. Pellegrini, L. Flatz, A. Bergthaler, K. Honda, B. Ludewig, et al. (2009)
Blood 113, 1045-1052
   Abstract »    Full Text »    PDF »
TLR7 Ligands Induce Higher IFN-{alpha} Production in Females.
B. Berghofer, T. Frommer, G. Haley, L. Fink, G. Bein, and H. Hackstein (2006)
J. Immunol. 177, 2088-2096
   Abstract »    Full Text »    PDF »
Gene Expression Studies in Systemic Lupus Erythematosus.
M Mandel and A Achiron (2006)
Lupus 15, 451-456
   Abstract »    PDF »
Type I interferon correlates with serological and clinical manifestations of SLE.
M C Dall'Era, P M Cardarelli, B T Preston, A Witte, and J C Davis Jr (2005)
Ann Rheum Dis 64, 1692-1697
   Abstract »    Full Text »    PDF »
Cross-regulation of TNF and IFN-{alpha} in autoimmune diseases.
A. K. Palucka, J.-P. Blanck, L. Bennett, V. Pascual, and J. Banchereau (2005)
PNAS 102, 3372-3377
   Abstract »    Full Text »    PDF »
IFN-{alpha} Induces Early Lethal Lupus in Preautoimmune (New Zealand Black x New Zealand White)F1 but Not in BALB/c Mice.
A. Mathian, A. Weinberg, M. Gallegos, J. Banchereau, and S. Koutouzov (2005)
J. Immunol. 174, 2499-2506
   Abstract »    Full Text »    PDF »
Expansion of Bone Marrow IFN-{alpha}-Producing Dendritic Cells in New Zealand Black (NZB) Mice: High Level Expression of TLR9 and Secretion of IFN-{alpha} in NZB Bone Marrow.
Z.-X. Lian, K. Kikuchi, G.-X. Yang, A. A. Ansari, S. Ikehara, and M. E. Gershwin (2004)
J. Immunol. 173, 5283-5289
   Abstract »    Full Text »    PDF »
Type I IFN Protects Against Murine Lupus.
J. D. Hron and S. L. Peng (2004)
J. Immunol. 173, 2134-2142
   Abstract »    Full Text »    PDF »
IFN-{alpha} Priming Results in a Gain of Proinflammatory Function by IL-10: Implications for Systemic Lupus Erythematosus Pathogenesis.
M. N. Sharif, I. Tassiulas, Y. Hu, I. Mecklenbrauker, A. Tarakhovsky, and L. B. Ivashkiv (2004)
J. Immunol. 172, 6476-6481
   Abstract »    Full Text »    PDF »
Fc{gamma}RIIa Is Expressed on Natural IFN-{alpha}-Producing Cells (Plasmacytoid Dendritic Cells) and Is Required for the IFN-{alpha} Production Induced by Apoptotic Cells Combined with Lupus IgG.
U. Bave, M. Magnusson, M.-L. Eloranta, A. Perers, G. V. Alm, and L. Ronnblom (2003)
J. Immunol. 171, 3296-3302
   Abstract »    Full Text »    PDF »
Interferon and Granulopoiesis Signatures in Systemic Lupus Erythematosus Blood.
L. Bennett, A. K. Palucka, E. Arce, V. Cantrell, J. Borvak, J. Banchereau, and V. Pascual (2003)
J. Exp. Med. 197, 711-723
   Abstract »    Full Text »    PDF »
Type-I Interferon Receptor Deficiency Reduces Lupus-like Disease in NZB Mice.
M.-L. Santiago-Raber, R. Baccala, K. M. Haraldsson, D. Choubey, T. A. Stewart, D. H. Kono, and A. N. Theofilopoulos (2003)
J. Exp. Med. 197, 777-788
   Abstract »    Full Text »    PDF »
Circulating human plasmacytoid dendritic cells are highly sensitive to corticosteroid administration.
M Shodell, K Shah, and F P Siegal (2003)
Lupus 12, 222-230
   Abstract »    PDF »
Induction of Dendritic Cell Differentiation by IFN-alpha in Systemic Lupus Erythematosus.
P. Blanco, A. K. Palucka, M. Gill, V. Pascual, and J. Banchereau (2001)
Science 294, 1540-1543
   Abstract »    Full Text »    PDF »
Activation of type I interferon system in systemic lupus erythematosus correlates with disease activity but not with antiretroviral antibodies.
A A Bengtsson, G Sturfelt, L Truedsson, J Blomberg, G Alm, H Vallin, and L Ronnblom (2000)
Lupus 9, 664-671
   Abstract »    PDF »
Purification, Microsequencing, and Immunolocalization of p36, a New Interferon-alpha-induced Protein That Is Associated with Human Lupus Inclusions.
S. A. Rich, M. Bose, P. Tempst, and U. H. Rudofsky (1996)
J. Biol. Chem. 271, 1118-1126
   Abstract »    Full Text »    PDF »
{beta}2-Microglobulin and the Acquired Immunodeficiency Syndrome in a Low-Incidence Area.
A. Schattner (1985)
JAMA 253, 43-44
   Abstract »    PDF »
Persisting Illness and Fatigue in Adults with Evidence of Epstein-Barr Virus Infection.
S. E. STRAUS, G. TOSATO, G. ARMSTRONG, T. LAWLEY, O. T. PREBLE, W. HENLE, R. DAVEY, G. PEARSON, J. EPSTEIN, I. BRUS, et al. (1985)
Ann Intern Med 102, 7-16
   Abstract »    PDF »
Cryptosporidiosis in a Patient with Hemophilia, Common Variable Hypogammaglobulinemia, and the Acquired Immunodeficiency Syndrome.
K. L. KOCH, T. V. SHANKEY, G. S. WEINSTEIN, R. E. DYE, A. B. ABT, W. L. CURRENT, and M. E. EYSTER (1983)
Ann Intern Med 99, 337-340
   Abstract »    PDF »
Acquired Immunodeficiency Syndrome, Opportunistic Infections, and Malignancies in Male Homosexuals: A Hypothesis of Etiologic Factors in Pathogenesis.
J. Sonnabend, S. S. Witkin, and D. T. Purtilo (1983)
JAMA 249, 2370-2374
   Abstract »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)